PharmiWeb.com - Global Pharma News & Resources
20-Dec-2019

Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year

EQS Group-News: Zur Rose Group AG / Key word(s): Joint Venture
20.12.2019 / 07:00

Frauenfeld und Winterthur, 20 December 2019

Press release

Cooperation between Medbase and Zur Rose

The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year

The joint ventures announced between Zur Rose and Medbase - a subsidiary of Migros - will start operations on 1 January 2020. They concern the roll-out of shop-in-shop pharmacies in Migros branches and a webshop for consumer health and personal care products respectively.

Following the successful pilot phase with the three current shop-in-shop pharmacies in Migros branches in Bern, Basel and Zurich, the two companies have agreed to extend the roll-out of the concept under the Zur Rose brand through a joint venture. To this end, the existing shop-in-shop pharmacies and the Zur Rose pharmacy at Welle 7 in Bern will be transferred to the joint venture with effect from 1 January 2020. Further shop-in-shop pharmacies are planned in the Migros supermarket in Crissier in the canton of Vaud and in the Tivoli shopping centre in Spreitenbach. Additional locations are being evaluated.

The shop-in-shop pharmacies provide a convenient way for customers to combine their daily shopping in Migros with buying medicines and pharmacy-exclusive healthcare and cosmetic products, while also enjoying the advantages of the ability to shop across channels.

The second joint venture between Medbase and Zur Rose is a collaboration in e-commerce: from the start of next year the two partners will be operating a joint webshop for consumer health and personal care products, again under the Zur Rose brand (www.zurrose-shop.ch). In the medium term the company intends to operate the webshop as a marketplace where other partners can also offer their products.

Pictures:

The following link provides print-quality images that can be used for media reporting: www.zurrosegroup.com/websites/zurrosegroup/German/201010/medienmitteilung.html?newsID=1634399

 

Contact:

Pascale Ineichen, Corporate Communications Zur Rose Suisse AG
Direct line +41 52 724 08 18 | Email media@zurrose.com

Sonja Benninger, Marketing/Communications Medbase Group
Direct line +41 52 260 29 16 | Email : sonja.benninger@medbase.ch

Zur Rose Suisse AG

Zur Rose Suisse AG, a subsidiary of Zur Rose Group AG, is one of Switzerland's leading mail-order pharmacies and medical wholesalers. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management and actively promotes its positioning as a comprehensive, integrated cross-service healthcare platform. The creation of added value and a pronounced patient orientation make it an important strategic partner for service providers, payers and industry.
The Zur Rose Group is Europe's largest mail-order pharmacy. For further information please see zurrosegroup.com.

Medbase Group

The Medbase Group is Switzerland's leading provider of outpatient healthcare services, operating medical centres in over 50 locations. Patients receive holistic care covering everything from prevention to acute medicine and rehabilitation. Some 300 general practitioners and specialists and over 360 therapists work in coordination across disciplines within the Group. For companies, Medbase Corporate Health offers customised consultancy services and full projects in occupational healthcare management. For further information please see www.medbase.ch.



End of Corporate News


Language: English
Company: Zur Rose Group AG
Walzm├╝hlestrasse 60
8500 Frauenfeld
Switzerland
Phone: +41 52 724 08 14
Internet: www.zurrosegroup.com
ISIN: CH0042615283
Listed: SIX Swiss Exchange
EQS News ID: 941043

 
End of News EQS Group News Service

Editor Details

Last Updated: 20-Dec-2019